Search research articles
Contact Us
Filters
Showing results (21-30 of 50) with videos related to
Page
of 5
Sort By:
Neurology
|
December 14, 2011
Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
T F Scott, E M Frohman, J De Seze, et al.
Journal of the Neurological Sciences
|
November 1, 1991
Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease
E M Frohman, T C Frohman, S Gupta, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 20, 2001
Ocular contrapulsion in multiple sclerosis: clinical features and pathophysiological mechanisms
E M Frohman, T C Frohman, J Fleckenstein, et al.
Neurology
|
June 17, 2009
Pearls & Oy-sters: "Not multiple sclerosis" and the changing face of HTLV-1: A case report of downbeat nystagmus
L R Beeravolu, E M Frohman, T C Frohman, et al.
Neurology
|
November 30, 2000
Vertigo in MS: utility of positional and particle repositioning maneuvers
E M Frohman, H Zhang, R B Dewey, et al.
Neurology
|
September 12, 2001
MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis
E M Frohman, H Zhang, P D Kramer, et al.
Neurology
|
April 23, 2008
Pearls & Oy-sters: The medial longitudinal fasciculus in ocular motor physiology
T C Frohman, S Galetta, R Fox, et al.
Journal of Neuroimmunology
|
August 1, 1991
Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line
R M Ransohoff, C Devajyothi, M L Estes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 30, 2004
Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
E M Frohman, K Brannon, Sherry Alexander, et al.
Neurology
|
March 29, 2007
Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
D S Goodin, E M Frohman, B Hurwitz, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 50) with videos related to
Sort By:
Page
of 5
Neurology
|
December 14, 2011
Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
T F Scott, E M Frohman, J De Seze, et al.
Journal of the Neurological Sciences
|
November 1, 1991
Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease
E M Frohman, T C Frohman, S Gupta, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 20, 2001
Ocular contrapulsion in multiple sclerosis: clinical features and pathophysiological mechanisms
E M Frohman, T C Frohman, J Fleckenstein, et al.
Neurology
|
June 17, 2009
Pearls & Oy-sters: "Not multiple sclerosis" and the changing face of HTLV-1: A case report of downbeat nystagmus
L R Beeravolu, E M Frohman, T C Frohman, et al.
Neurology
|
November 30, 2000
Vertigo in MS: utility of positional and particle repositioning maneuvers
E M Frohman, H Zhang, R B Dewey, et al.
Neurology
|
September 12, 2001
MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis
E M Frohman, H Zhang, P D Kramer, et al.
Neurology
|
April 23, 2008
Pearls & Oy-sters: The medial longitudinal fasciculus in ocular motor physiology
T C Frohman, S Galetta, R Fox, et al.
Journal of Neuroimmunology
|
August 1, 1991
Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line
R M Ransohoff, C Devajyothi, M L Estes, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 30, 2004
Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
E M Frohman, K Brannon, Sherry Alexander, et al.
Neurology
|
March 29, 2007
Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
D S Goodin, E M Frohman, B Hurwitz, et al.
Page
of 5